| Financial Year |
March 31 2023 |
| Monetary Funds |
1,898,544,294.47 |
| Held-for-trading Financial Assets |
1,643,198,367.09 |
| Notes Receivable |
-- |
| Accounts Receivable |
144,925,013.77 |
| Advances to Suppliers |
21,988,175.20 |
| Other Receivables |
15,466,816.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
196,608,892.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,352,649.07 |
| Total Current Assets |
3,948,084,209.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
9,271,441.67 |
| Fixed Assetes |
252,767,281.72 |
| Under-construction Projects |
132,308,644.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
92,535,676.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,627,506.81 |
| Deferred Income Tax Assets |
51,714,133.12 |
| Other Non-Current Assets |
9,262,248.00 |
| Sub-Total of Non-Current Assets |
620,071,530.69 |
| Total Assets |
4,568,155,740.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
22,715,554.14 |
| Notes Payable |
-- |
| Accounts Payable |
128,925,569.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,119,289.95 |
| Taxes Payable |
80,073,928.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,564,568.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,748,665.93 |
| Other Current Liabilities |
2,479,582.09 |
| Sub-Total of Current Liabilities |
328,739,728.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,039,755.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,756,564.49 |
| Total Liabilities |
350,496,292.76 |
| Paid-In Capital(Or Share Stock) |
53,904,145.00 |
| Capital Surplus |
1,750,499,845.12 |
| Surplus Reserve |
248,080,319.84 |
| LESS:Treasury Stock |
115,556,894.19 |
| Undistributed Profits |
2,248,218,672.83 |
| Minority Stockholder's Interest |
4,462,694.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,213,196,753.01 |
| Owner's Equity（Stockholder's Equity） |
4,217,659,447.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,568,155,740.18 |
